Skip to main content
Onyema Ogbuagu, MD, Infectious Disease, New Haven, CT, Yale-New Haven Hospital

OnyemaEberechukwuOgbuaguMD

Infectious Disease New Haven, CT

Assistant Professor, Internal Medicine, Yale University School of Medicine

Are you Dr. Ogbuagu?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 40 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Onyema Ogbuagu, MD is an infectious disease specialist in New Haven, Connecticut. He is currently licensed to practice medicine in Connecticut and New York. He is affiliated with Yale-New Haven Hospital and MidState Medical Center.

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Infectious Disease, 2010 - 2012
  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2006 - 2010
  • University of Calabar Faculty of Medicine
    University of Calabar Faculty of MedicineClass of 2003

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2011 - 2024
  • NY State Medical License
    NY State Medical License 2010 - 2011
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

Authored Content

  • Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
  • Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
  • Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
  • Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
  • Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
  • Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
  • Join now to see all

Press Mentions

  • Fact Check: COVID-19 Vaccination Decreases Chances of Hospitalization, Contrary to Post's Implication
    Fact Check: COVID-19 Vaccination Decreases Chances of Hospitalization, Contrary to Post's ImplicationJanuary 24th, 2023
  • New Clinical Data Support the Sustained Efficacy of Long-Acting Lenacapavir, Gilead’s Investigational HIV-1 Capsid Inhibitor
    New Clinical Data Support the Sustained Efficacy of Long-Acting Lenacapavir, Gilead’s Investigational HIV-1 Capsid InhibitorFebruary 16th, 2022
  • Faces of the Unvaccinated: Nurse Contracts COVID for a Second Time After Refusing to Get Vaccinated
    Faces of the Unvaccinated: Nurse Contracts COVID for a Second Time After Refusing to Get VaccinatedFebruary 4th, 2022
  • Join now to see all

Hospital Affiliations